Precision Medicine in Cytopathology.

Area of Science:

• Oncology
• Pathology
• Medical Diagnostics

Background:

• Cancer diagnostics have evolved significantly over the past decade, marked by increasing complexity.
• Minimally invasive diagnostic tests, advanced imaging, and early detection protocols are transforming patient care.
• Cytopathologists play a crucial role in preserving patient samples for essential biomarker and molecular testing.

Purpose of the Study:

• To explore ancillary testing modalities in cancer diagnostics.
• To examine the role of biomarkers in organ-specific cancer contexts.
• To highlight the impact of precision medicine on cancer treatment strategies.

Main Methods:

• Review of ancillary testing modalities.
• Analysis of biomarker roles in various organ-specific cancers.
• Discussion of precision medicine's influence on targeted cancer therapies.

Main Results:

• Ancillary testing and biomarker analysis are integral to modern cytopathology.
• Biomarkers are crucial for personalized cancer care and treatment selection.
• The development of over 80 FDA-approved predictive biomarkers signifies a paradigm shift.

Conclusions:

• Precision medicine, driven by advanced diagnostics and biomarkers, is revolutionizing cancer care.
• Personalized and targeted treatment strategies are becoming the standard in oncology.
• The integration of molecular testing ensures more accurate and effective cancer management.